Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States?

Cancer

Volumn 121, Issue 13, 2015, Pages 2127-2128

  Paskett, Electra D ^a   Khuri, Fadlo R ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HUMAN; MEDICALLY UNDERSERVED; PRIORITY JOURNAL; REMINDER SYSTEM; SELF REPORT; UNITED STATES; COLORECTAL NEOPLASMS; MASS SCREENING; OCCULT BLOOD;

COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; MASS SCREENING; OCCULT BLOOD; UNITED STATES;

EID: 84931577057     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29335     Document Type: Editorial

References (21)

1. Meester RG, Doubeni CA, Zauber AG, et al., Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015; 121: 2281-2285.
2. American Cancer Society. Cancer Facts & Figures, 2015. Atlanta, GA: American Cancer Society; 2015.
3. Centers for Disease Control and Prevention. National Health Interview Survey. Available at: http://www.cdc.gov/nchs/nhis.htm. Accessed February 13, 2015.
4. Reiter PL, Katz ML, Oliveri JM, Young GS, Llanos AA, Paskett ED., Validation of self-reported colorectal cancer screening behaviors among Appalachian residents. Public Health Nurs. 2013; 30: 312-322.
5. Qaseem A, Denberg TD, Hopkins RH, et al,; Clinical Guidelines Committee of the American College of Physicians. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012; 156: 378-386.
6. Levin B, Lieberman DA, McFarland B, et al,; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology, CA Cancer J Clin. 2008; 58: 130-160.
7. Zauber AG, Winawer SJ, O'Brien MJ, et al., Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012; 366: 687-696.
8. Atkin WS, Edwards R, Kralj-Hans I, et al,; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicenter randomized trial. Lancet. 2010; 375: 1624-1633.
9. Hardcastle JD, Chamberlain JO, Robinson MH, et al., Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
10. Segnan N, Armaroli P, Bonelli L, et al,; SCORE Working Group. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst. 2011; 103: 1310-1322.
11. Quintero E, Castells A, Bujanda L, et al,; COLONPREV Study Investigators. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012; 366: 697-706.
12. Ramdass P, Petraro P, Via C, Shahrokni A, Nawaz H., Providers role in colonoscopy screening for colorectal cancer. Am J Health Behav. 2014; 38: 234-244.
13. Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ., Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med. 2009; 169: 364-371.
14. Lasser KE, Murillo J, Lisboa S, et al., Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011; 171: 906-912.
15. Pignone M, Winquist A, Schild LA, et al., Effectiveness of a patient and practice-level colorectal cancer screening intervention in health plan members: the CHOICE trial. Cancer. 2011; 117: 3352-3362.
16. Wang CY, de Dieu Tapsoba J, Anderson ML, et al., Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014; 23: 1683-1688.
17. Clouston K, Katz A, Martens PJ, et al,; CIHR/CCMB Team in Primary Care Oncology (PCO-NET). Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results form a pragmatic cluster randomized controlled trial. BMC Cancer. 2014; 14: 263.
18. Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D., Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomized trial. Br J Cancer. 2011; 105: 475-480.
19. Wu XC, Lund MJ, Kimmick GG, et al., Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol. 2012; 30: 142-150.
20. Bradley CJ, Given CW, Dahman B, Fitzgerald TL., Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Arch Intern Med. 2008; 168: 521-529.
21. Grubbs SS, Polite BN, Carney J, et al., Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013; 31: 1928-1930.